Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
CAST$1.29-0.07(-5.07%)From Global Private Credit to Programmable Securities: New to The Street Show #778 Premieres Tonight on Bloomberg Television[11:00:00 AM ET]DMGGF$0.27-0.02(-7.78%)DMG Blockchain Solutions Issues Statement Regarding the Binance Security Incident and Provides Update on Patents Granted[12:31:27 AM ET]OFRM$15.02-0.95(-5.95%)Once Upon a Farm Announces Recall and Reformulation of Tractor Wheels™ Due to Potential Choking Hazard[10:37:00 PM ET]FANCF$0.42-0.02(-3.99%)First Atlantic to Acquire 100% of the North Arm Project, 52 sq km of Mantle-Derived Ultramafic Rocks in Western Newfoundland Never Systematically Tested for Geologic Hydrogen, Chromium or Awaruite Nickel-Cobalt Alloy[8:30:00 PM ET]NEXNF$0.09-0.00(-2.45%)NEXE Innovations Reports Q1 Fiscal 2027 Results and Business Update[8:03:56 PM ET]UREKF$0.120.00(0.00%)Eureka Metals Corp. Announces Rights Offering and Proposed Share Consolidation[7:57:00 PM ET]RMBI$15.860.00(0.00%)RICHMOND MUTUAL BANCORPORATION, INC. ANNOUNCES 2026 THIRD QUARTER FINANCIAL RESULTS Richmond Mutual Bancorporation, Inc., a Maryland corporation (the "Company") (NASDAQ: RMBI), parent company of First Bank Midwest, today reported net ...[7:55:00 PM ET]MVLY$21.69+0.73(+3.48%)Mission Valley Bancorp Reports Third Quarter Results[7:52:00 PM ET]UNIB$21.350.00(0.00%)University Bancorp Closes on the Acquisition of 20% of UIF Corporation for Cash & Stock Worth About $15.2 Million[7:45:00 PM ET]NXTT$5.02+0.17(+3.51%)Next Technology Holding Inc. Announces Board Authorization to Sell or Pledge of Bitcoin Holdings to Reduce Bitcoin Exposure and Enhance Liquidity[7:20:00 PM ET]PRRSF$0.04+0.00(+10.13%)Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement[6:35:00 PM ET]

QGEN · NYSE

Qiagen N.V.

$50.17 -0.16 (-0.31%)

Company overview

QIAGEN N.V. offers sample-to-insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, including nucleic acid stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies. It also offers secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials, and instruments for nucleic acid purification and accessories.

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NYSE
Market cap
$10.3B
Employees
5,700
Headquarters
Venlo
Website
qiagen.com
CEO
Thierry L. Bernard
Listed
June 28, 1996
P/E
26.55
Dividend yield
6.82%

Company financials

Revenue
$2.1B
Gross profit
$1.3B
Operating income
$522M
EBITDA
$695M
Net income
$402M
EPS
$1.89
Total assets
$5.8B
Total debt
$1.6B
Gross margin
61.58%
Net margin
19.16%
Earnings yield
3.77%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

Showing FY 2025

Price chart

31.8036.7441.6846.6151.55
QGEN 1D NYSE O50.35H50.39L50.07C50.22-0.12 (-0.24%)Vol4.17M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
Ticker Type Headline Source Published
QGENQiagen N.V. Stock news Do Options Traders Know Something About Qiagen Stock We Don't? Zacks Investment Research
QGENQiagen N.V. Stock news Qiagen (QGEN) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release Zacks Investment Research
QGENQiagen N.V. Legal Halper Sadeh LLC is Investigating Whether ULBI, QGEN, CCC, PAG are Obtaining Fair Deals for their Shareholders GlobeNewswire
QGENQiagen N.V. Legal BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ultralife Corporation (Nasdaq – ULBI), QIAGEN N.V. (NYSE – QGEN), CCC Intelligent Solutions Holdings Inc. GlobeNewsWire
QGENQiagen N.V. Legal Halper Sadeh LLC is Investigating Whether QGEN, VCTR, RLYB are Obtaining Fair Deals for their Shareholders GlobeNewswire
QGENQiagen N.V. Legal BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: QIAGEN N.V. (NYSE – QGEN), Varonis Systems, Inc. (Nasdaq – VRNS), CCC Intelligent Solutions Holdings Inc. GlobeNewswire
QGENQiagen N.V. Stock news This Qiagen Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday Benzinga
QGENQiagen N.V. Legal QGEN Stock Alert: Halper Sadeh LLC is Investigating Whether QIAGEN N.V. is Obtaining a Fair Price for its Shareholders Business Wire
QGENQiagen N.V. Press release QIAGEN reports preliminary Q3 2026 results Business Wire
QGENQiagen N.V. Press release QIAGEN and EQT Private Equity announce agreement on a recommended voluntary all-cash public takeover offer Business Wire
QGENQiagen N.V. Stock news 15,494 Shares of Qiagen N.V. $QGEN Bought by Cordatus Wealth Management LLC Defense World
QGENQiagen N.V. Press release QIAGEN Convenes Global Tuberculosis Experts as New Pressures Challenge Progress Against Tuberculosis Business Wire
QGENQiagen N.V. Stock news QIAGEN Expands AI-Powered Bioinformatics for Research and Drug Discovery Business Wire
QGENQiagen N.V. Stock news QIAGEN Expands US QIAstat-Dx Portfolio With New FDA-Cleared Panel Zacks Investment Research
QGENQiagen N.V. Stock news QIAGEN Completes U.S. QIAstat-Dx Bloodstream Infection Portfolio With FDA Clearance of New Bacteria Detection Panel Business Wire
QGENQiagen N.V. Stock news Qiagen N.V. (NYSE:QGEN) Stock Has Consensus Target Price of $43.51 Defense World
QGENQiagen N.V. Press release QIAGEN Launches QIAmini to Automate Small-Batch Sample Preparation Business Wire
QGENQiagen N.V. Stock news Here's Why You Should Hold QIAGEN Stock in Your Portfolio for Now Zacks Investment Research
QGENQiagen N.V. Stock news A Look at Qiagen NV (QGEN) After 3.4% Gain -- GF Value $49.88 vs Price $44.78 GuruFocus
QGENQiagen N.V. Press release QIAGEN Calls Extraordinary General Meeting for Appointment of Jonathan M. Pratt to Managing Board Business Wire
See more
FAQ

Questions about Qiagen N.V.

What does Qiagen N.V. do?
QIAGEN N.V. offers sample-to-insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, including nucleic acid stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies. It also offers secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials, and instruments for nucleic acid purification and accessories.
What is QGEN's market cap?
Qiagen N.V. (QGEN) is a listed stock with a live quote. The latest market cap on this page is $10.3B.
Where is Qiagen N.V. headquartered?
Qiagen N.V. is headquartered in Venlo.
How do I get QGEN news from the API?
Call GET /v1/news?tickers=QGEN. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does QGEN news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for QGEN, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the QGEN price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs